β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE, No. 45 β 30 APRIL 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Apo-Diltiazem CD
Diltiazem hydrochloride 180.1mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Apo-Diltiazem CD
Diltiazem hydrochloride 240.1mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Apo-Diltiazem CD
Diltiazem hydrochloride 300mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Spiriva Respimat
Tiotropium bromide monohydrate 3.125mcg equivalent to Tiotropium 2.5mcg/dose
Solution for inhalation
Boehringer Ingelheim (NZ) Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
Dated this 23rd day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go2488
Renewal of Provisional Consent to the Distribution of Medicines
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ketamine
Ketamine hydrochloride 1.153mg/mL equivalent to Ketamine 1mg/mL
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 5 May 2015.
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ketamine
Ketamine hydrochloride 4.613mg/mL equivalent to Ketamine 4mg/mL
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 5 May 2015.
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ketamine
Ketamine hydrochloride 11.53mg/mL equivalent to Ketamine 10mg/mL
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 5 May 2015.
Dated this 23rd day of April 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go2489
38
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare23 April 2015
Medicines, Distribution, Diltiazem, Tiotropium, Apotex, Boehringer Ingelheim
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
π₯ Renewal of Provisional Consent to the Distribution of Medicines
π₯ Health & Social Welfare23 April 2015
Medicines, Renewal, Ketamine, Biomed Limited
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 45